<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00845468</url>
  </required_header>
  <id_info>
    <org_study_id>07-4-B368-A1392-22379</org_study_id>
    <secondary_id>VF 20050103</secondary_id>
    <nct_id>NCT00845468</nct_id>
  </id_info>
  <brief_title>Coronary Flow Reserve and Glucometabolic State</brief_title>
  <official_title>Coronary Flow Velocity Reserve According to Glucometabolic State in Acute Myocardial Infarction; Relation to Ventricular Systolic and Diastolic Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medicinsk Forsknings Afdeling</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medicinsk Forsknings Afdeling</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diabetes mellitus is a major risk factor for the development of ischemic heart disease, and&#xD;
      patients with diabetes mellitus have a worse outcome following an acute myocardial infarction&#xD;
      than non-diabetic patients. Furthermore, abnormal glucose metabolism below the diagnostic&#xD;
      threshold of diabetes mellitus is also associated with increased risk of death compared to&#xD;
      patients with a normal glucose metabolism. The frequency of abnormal glucose metabolism in&#xD;
      acute myocardial infarction is high, and approximately 70% of myocardial infarction patients&#xD;
      have diabetes mellitus, newly diagnosed diabetes mellitus or impaired glucose tolerance,&#xD;
      leaving only 30% with normal glucose metabolism. The increased mortality among patients with&#xD;
      acute myocardial infarction and abnormal glucose metabolism seems mainly related to a higher&#xD;
      occurrence of congestive heart failure, suggesting that an abnormal glucose metabolism may&#xD;
      play an important role among others in endothelial dysfunction, infarct healing and overall&#xD;
      left ventricle function. This raises the question, whether patients with acute myocardial&#xD;
      infarction and abnormal glucose metabolism have increased frequency of micro- or&#xD;
      macrovascular disease or both.&#xD;
&#xD;
      Coronary flow velocity reserve reflects the patency of the epicardial coronary artery in&#xD;
      combination with vasodilator capacity of the microcirculation and may therefore offer a tool&#xD;
      for assessment of macro- and microcirculation.&#xD;
&#xD;
      This study will focus on the relation between coronary flow velocity reserve estimated by&#xD;
      transthoracal Doppler echocardiography and mortality, risk for heart failure and left&#xD;
      ventricle function after acute myocardial infarction stratified according to glycometabolic&#xD;
      state&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2006</start_date>
  <primary_completion_date type="Actual">August 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">190</enrollment>
  <condition>Acute Myocardial Infarction</condition>
  <condition>Diabetes Mellitus</condition>
  <condition>Prediabetes</condition>
  <arm_group>
    <arm_group_label>No treatment</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients suffering from a acute myocardial infarction&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Newly diagnosed first AMI based on characteristic clinical symptoms and/or&#xD;
             electrocardiographic signs of AMI and Troponin T or I or CK-MB over diagnostic limits&#xD;
             for AMI&#xD;
&#xD;
          2. Referral for coronary arteriography based on the actual myocardial infarction&#xD;
&#xD;
          3. Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Previous myocardial infarction&#xD;
&#xD;
          2. Asthma bronchiale&#xD;
&#xD;
          3. 2 or/and 3 degree atrio-ventricular block and paced rhythm&#xD;
&#xD;
          4. Mental state that makes the patient unavailable in attending the study&#xD;
&#xD;
          5. Use of dipyridamol&#xD;
&#xD;
          6. Sick Sinus Syndrome&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brian B Løgstrup, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medicinsk Forsknings Afdeling</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital of Fünen Svendborg</name>
      <address>
        <city>Svendborg</city>
        <zip>5700</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2009</verification_date>
  <study_first_submitted>February 17, 2009</study_first_submitted>
  <study_first_submitted_qc>February 17, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 18, 2009</study_first_posted>
  <last_update_submitted>February 17, 2009</last_update_submitted>
  <last_update_submitted_qc>February 17, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 18, 2009</last_update_posted>
  <responsible_party>
    <name_title>Brian Bridal Løgstrup</name_title>
    <organization>Medicinsk Forskning Afdeling</organization>
  </responsible_party>
  <keyword>coronary flow reserve</keyword>
  <keyword>diabetes mellitus</keyword>
  <keyword>acute myocardial infarction</keyword>
  <keyword>transthoracic echocardiography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

